-
-
-
-
-
-
-
Arcus Biosciences (RCUS) Misses Q1 EPS by 17c
-
-
-
-
-
-
-
Arcus Biosciences (RCUS) Tops Q4 EPS by 21c
-
-
-
-
-
-
-
Arcus Biosciences (RCUS) PT Raised to $32 at H.C. Wainwright
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Arcus Biosciences (RCUS)
-
-
-
-
-
-
-
Arcus Biosciences (RCUS) call put ratio 78 calls to 1 put with a focus on December 10 calls
-
-
-
-
-
-
-
Arcus Biosciences (RCUS) Tops Q3 EPS by 2c
-
-
-
-
-
-
-
Arcus Biosciences (RCUS) Secures Up to $250 Million Term Loan Facility from Hercules Capital
-
443,901 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

